- 2022 - 2026 1型糖尿病のエフェクター機能を反映した抗原特異的T細胞マーカーの開発
- 2022 - 2025 オンラインでの双方向性連携を活用した県内の医療施設での糖尿病治療標準化への有効性
- 2021 - 2024 膵島内環境における細胞代謝変化と自己免疫性糖尿病進展の関連性の検討
- 2021 - 2024 ICT連携の検査データ共有による糖尿病コントロールと歯周治療の数値的関係の解明
- 2016 - 2019 An explorative study for the therapeutic target in type 1 diabetes associated with pioneer transcription factor-IRF4
- 2012 - 2015 Development of effector cell-targeted treatment for the inhibition of type 1 diabetes
- 2011 - 2013 Investigation of autoantigens in patients with rheumatoid arthritis through protemic analysis: exploration from diagnosis, pathogenesis to therapy
- 2011 - 2013 Clarification of pathogenetic mechanisms of type 1 diabetes and its adaptation to prediction and prevention
- 2011 - 2012 Development of new therapy for type 1 diabetes targeting for IRF-4 (interferon regulatory factor-4)
- 2009 - 2011 Development of treatment for the inhibition of type 1 diabetes
- 2008 - 2010 Can we explain the varying pathologic processes of rheumatoid arthritis by CaMKII delta abnormality?
- 2008 - 2010 Studies on the pathogenesis of autoimmune thyroid diseases : using genetically-engineered mice
- 2008 - 2010 Development of predictive marker for the progression of type 1 diabetes using a newly discovered autoantigen
- 2005 - 2008 Antigen specific treatment for the inhibition and remission of type 1 diabetes with insulin B chain peptide
- 2006 - 2007 Development of predictive assay for progression of slow-onset type 1 diabetes and its application to disease prevention
Show all